662 related articles for article (PubMed ID: 27487218)
1. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis.
Strilic B; Yang L; Albarrán-Juárez J; Wachsmuth L; Han K; Müller UC; Pasparakis M; Offermanns S
Nature; 2016 Aug; 536(7615):215-8. PubMed ID: 27487218
[TBL] [Abstract][Full Text] [Related]
2. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
Kearney CJ; Cullen SP; Clancy D; Martin SJ
FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
[TBL] [Abstract][Full Text] [Related]
3. Critical contribution of oxidative stress to TNFα-induced necroptosis downstream of RIPK1 activation.
Shindo R; Kakehashi H; Okumura K; Kumagai Y; Nakano H
Biochem Biophys Res Commun; 2013 Jun; 436(2):212-6. PubMed ID: 23727581
[TBL] [Abstract][Full Text] [Related]
4. Multi-Arm PEG/Peptidomimetic Conjugate Inhibitors of DR6/APP Interaction Block Hematogenous Tumor Cell Extravasation.
Wang L; Shen Q; Liao H; Fu H; Wang Q; Yu J; Zhang W; Chen C; Dong Y; Yang X; Guo Q; Zhang J; Zhang J; Zhang W; Lin H; Duan Y
Adv Sci (Weinh); 2021 Jun; 8(11):e2003558. PubMed ID: 34105277
[TBL] [Abstract][Full Text] [Related]
5. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
[TBL] [Abstract][Full Text] [Related]
6. Sibiriline, a new small chemical inhibitor of receptor-interacting protein kinase 1, prevents immune-dependent hepatitis.
Le Cann F; Delehouzé C; Leverrier-Penna S; Filliol A; Comte A; Delalande O; Desban N; Baratte B; Gallais I; Piquet-Pellorce C; Faurez F; Bonnet M; Mettey Y; Goekjian P; Samson M; Vandenabeele P; Bach S; Dimanche-Boitrel MT
FEBS J; 2017 Sep; 284(18):3050-3068. PubMed ID: 28715128
[TBL] [Abstract][Full Text] [Related]
7. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.
Newton K; Dugger DL; Wickliffe KE; Kapoor N; de Almagro MC; Vucic D; Komuves L; Ferrando RE; French DM; Webster J; Roose-Girma M; Warming S; Dixit VM
Science; 2014 Mar; 343(6177):1357-60. PubMed ID: 24557836
[TBL] [Abstract][Full Text] [Related]
8. TAK1 regulates endothelial cell necroptosis and tumor metastasis.
Yang L; Joseph S; Sun T; Hoffmann J; Thevissen S; Offermanns S; Strilic B
Cell Death Differ; 2019 Oct; 26(10):1987-1997. PubMed ID: 30683914
[TBL] [Abstract][Full Text] [Related]
9. RIPK1 promotes death receptor-independent caspase-8-mediated apoptosis under unresolved ER stress conditions.
Estornes Y; Aguileta MA; Dubuisson C; De Keyser J; Goossens V; Kersse K; Samali A; Vandenabeele P; Bertrand MJ
Cell Death Dis; 2014 Dec; 5(12):e1555. PubMed ID: 25476903
[TBL] [Abstract][Full Text] [Related]
10. Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathways.
Tanzer MC; Khan N; Rickard JA; Etemadi N; Lalaoui N; Spall SK; Hildebrand JM; Segal D; Miasari M; Chau D; Wong WL; McKinlay M; Chunduru SK; Benetatos CA; Condon SM; Vince JE; Herold MJ; Silke J
Cell Death Differ; 2017 Mar; 24(3):481-491. PubMed ID: 28106882
[TBL] [Abstract][Full Text] [Related]
11. Necroptosis is a key mediator of enterocytes loss in intestinal ischaemia/reperfusion injury.
Wen S; Ling Y; Yang W; Shen J; Li C; Deng W; Liu W; Liu K
J Cell Mol Med; 2017 Mar; 21(3):432-443. PubMed ID: 27677535
[TBL] [Abstract][Full Text] [Related]
12. Rip1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury.
Linkermann A; Bräsen JH; Himmerkus N; Liu S; Huber TB; Kunzendorf U; Krautwald S
Kidney Int; 2012 Apr; 81(8):751-61. PubMed ID: 22237751
[TBL] [Abstract][Full Text] [Related]
13. Negatively-regulated necroptosis by autophagy required caspase-6 activation in TNFα-treated murine fibrosarcoma L929 cells.
Ye YC; Wang HJ; Chen L; Liu WW; Tashiro S; Onodera S; Xia MY; Ikejima T
Int Immunopharmacol; 2013 Nov; 17(3):548-55. PubMed ID: 23941769
[TBL] [Abstract][Full Text] [Related]
14. TWEAK and RIPK1 mediate a second wave of cell death during AKI.
Martin-Sanchez D; Fontecha-Barriuso M; Carrasco S; Sanchez-Niño MD; Mässenhausen AV; Linkermann A; Cannata-Ortiz P; Ruiz-Ortega M; Egido J; Ortiz A; Sanz AB
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4182-4187. PubMed ID: 29588419
[TBL] [Abstract][Full Text] [Related]
15. The role of necroptosis, an alternative form of cell death, in cancer therapy.
Yu X; Deng Q; Bode AM; Dong Z; Cao Y
Expert Rev Anticancer Ther; 2013 Jul; 13(7):883-93. PubMed ID: 23875666
[TBL] [Abstract][Full Text] [Related]
16. Intracellular pH Regulates TRAIL-Induced Apoptosis and Necroptosis in Endothelial Cells.
Zhang ZX; Gan I; Pavlosky A; Huang X; Fuhrmann B; Jevnikar AM
J Immunol Res; 2017; 2017():1503960. PubMed ID: 28884134
[TBL] [Abstract][Full Text] [Related]
17. Complex roles of necroptosis in cancer.
Zhu F; Zhang W; Yang T; He SD
J Zhejiang Univ Sci B; 2019 May; 20(5):399-413. PubMed ID: 31090266
[TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of NTB451 as a Potential Inhibitor of Necroptosis.
In EJ; Lee Y; Koppula S; Kim TY; Han JH; Lee KH; Kang TB
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400632
[TBL] [Abstract][Full Text] [Related]
19. The evidence for and against different modes of tumour cell extravasation in the lung: diapedesis, capillary destruction, necroptosis, and endothelialization.
Paku S; Laszlo V; Dezso K; Nagy P; Hoda MA; Klepetko W; Renyi-Vamos F; Timar J; Reynolds AR; Dome B
J Pathol; 2017 Mar; 241(4):441-447. PubMed ID: 28026875
[TBL] [Abstract][Full Text] [Related]
20. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome.
Duprez L; Takahashi N; Van Hauwermeiren F; Vandendriessche B; Goossens V; Vanden Berghe T; Declercq W; Libert C; Cauwels A; Vandenabeele P
Immunity; 2011 Dec; 35(6):908-18. PubMed ID: 22195746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
